We are live on ! Find out more
FI

Fosun International Portfolio holdings

AUM $399M
1-Year Est. Return 16.11%
This Fund
S&P 500
This Quarter Est. Return
-18.56%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.67B
AUM Growth
-$412M
Cap. Flow
+$65.2M
Cap. Flow %
3.89%
Top 10 Hldgs %
54.47%
Holding
343
New
97
Increased
69
Reduced
59
Closed
44

Sector Composition

Rank Sector Weight
1 Healthcare 39.37%
2 Financials 7.66%
3 Consumer Discretionary 5.31%
4 Communication Services 3.82%
5 Industrials 2.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RARX
76
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$1.97M 0.12%
+108,073
New +$1.7M
OPK icon
77
Opko Health
OPK
$985M
$1.94M 0.12%
768,142
+215,000
+39% +$729K
AAPL icon
78
Apple
AAPL
$4.54T
$1.91M 0.11%
49,000
+9,880
+25% +$479K
ALDR
79
DELISTED
Alder Biopharmaceuticals
ALDR
$1.89M 0.11%
184,813
+25,000
+16% +$320K
HDB icon
80
HDFC Bank
HDB
$123B
$1.87M 0.11%
73,280
KO icon
81
Coca-Cola
KO
$377B
$1.85M 0.11%
39,000
-700
-2% -$33.5K
BABA icon
82
Alibaba
BABA
$293B
$1.83M 0.11%
13,235
-3,385
-20% -$500K
BRK.A icon
83
Berkshire Hathaway Class A
BRK.A
$1.1T
$1.79M 0.11%
6
-1
-14% -$313K
PGNX
84
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$1.77M 0.11%
454,588
+56,000
+14% +$285K
TSM icon
85
TSMC
TSM
$2.1T
$1.77M 0.11%
48,120
-12,400
-20% -$472K
EIGR
86
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.69M 0.1%
+6,060
New +$1.96M
ADMS
87
DELISTED
Adamas Pharmaceuticals
ADMS
$1.66M 0.1%
196,959
+136,959
+228% +$1.78M
LLY icon
88
Eli Lilly
LLY
$1.02T
$1.66M 0.1%
14,660
-4,640
-24% -$518K
ZGNX
89
DELISTED
Zogenix, Inc.
ZGNX
$1.61M 0.1%
+45,700
New +$1.87M
PYPL icon
90
PayPal
PYPL
$48.9B
$1.6M 0.1%
+19,020
New +$1.58M
HD icon
91
Home Depot
HD
$331B
$1.59M 0.1%
9,290
+190
+2% +$34.1K
SLG icon
92
SL Green Realty
SLG
$3.76B
$1.59M 0.1%
20,660
+10,330
+100% +$914K
NKE icon
93
Nike
NKE
$61.9B
$1.57M 0.09%
21,327
-15,300
-42% -$1.14M
VEON icon
94
VEON
VEON
$3.62B
$1.55M 0.09%
26,424
HRTX icon
95
Heron Therapeutics
HRTX
$93.9M
$1.54M 0.09%
+65,557
New +$1.8M
MO icon
96
Altria Group
MO
$114B
$1.51M 0.09%
30,800
+12,000
+64% +$695K
JG
97
Aurora Mobile
JG
$33.4M
$1.51M 0.09%
10,724
ATRS
98
DELISTED
Antares Pharma, Inc.
ATRS
$1.41M 0.08%
+539,600
New +$1.78M
CB icon
99
Chubb
CB
$135B
$1.41M 0.08%
10,981
+4,600
+72% +$594K
PG icon
100
Procter & Gamble
PG
$336B
$1.4M 0.08%
15,200
-9,500
-38% -$849K

Similar funds

Fosun International's Q4 2018 Portfolio in Review

As of Q4 2018, Fosun International held 343 positions worth $1.67B, down 20% from $2.09B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Fosun International deployed $65.2M of net new capital in Q4 2018, opening 97 new positions and adding to 69 existing holdings. Its largest new stake was Albireo Pharma Inc: 197,005 shares worth $4.49M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 44% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Brookdale Senior Living, an estimated $57.6M trimmed.

  • Fosun International's largest Q4 2018 buy was Albireo Pharma Inc: 197,005 shares worth $4.49M.
  • Fosun International added most to Seadrill Limited Common Stock in Q4 2018, an estimated $25.6M increase.
  • Fosun International's biggest Q4 2018 reduction was Brookdale Senior Living, cutting an estimated $57.6M.
  • Fosun International fully exited Bilibili in Q4 2018, selling an estimated $13M.
  • Fosun International's ten largest holdings make up 54% of its $1.67B portfolio in Q4 2018.
  • Fosun International opened 97 new positions and closed 44 in Q4 2018.
  • Fosun International's portfolio value fell 20% quarter-over-quarter to $1.67B.

Based on Fosun International's 13F filing for Q4 2018, filed 31 Jan 2019.